ArticleEuropean heart journal2011

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

Tina Ken Schramm et al.PubMed ↗Publisher ↗

No numbers read from the abstract.